Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023

Published on March 2, 2023

This report describes interim clinical treatments for severe mpox developed following the evaluation of treatment data, cases, input from clinicians, and more.

Continue reading on website
Other news

Notes from the Field: Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 - New York City, November 1, 2022-January 4, 2023

February 23, 2023
This report describes characteristics of the XBB 1.5 Variant in New York City during November-December 2022.

Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections - Colorado and Minnesota, October-December 2022

March 9, 2023
This report describes surveillance of a resurgence of invasive group A Streptococcus in children and adolescents in Colorado and Minnesota.